OBIO
Orchestra BioMed Holdings, Inc.Company with tickers: OBIO
CIK
1814114
CUSIP
68572M106
Shares Outstanding
59,880,715
13F Activity (30d)
55 filings
55 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $110,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $32,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $15,781,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Income | $-22,076,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $-20,691,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-0.33 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-0.33 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |